Delivery Order SPE2DB20D1109-SPE2DB25FM95T

Award Date 10/18/24
Potential Completion Date 10/21/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,580.67, is for the delivery of Repatha 140 mg/mL SureClick autoinjectors, a specialty medication used to treat cardiovascular conditions. The contract has an ultimate completion date of March 25, 2024 and is a firm fixed-price contract. This contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $3,065.81. The contract is for the supply of Repatha 140 mg/mL SureClick injection medication, which is used to treat cardiovascular conditions. The contract has an ultimate completion date of January 9, 2025 and is structured as a firm fixed-price delivery order. There is no set-aside designation on this contract....
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,051.98, is for the supply of Repatha 140 mg/mL SureClick medication. It is a Firm Fixed Price contract with an ultimate completion date of December 30, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $1,324.90 and has a completion date of November 21, 2023. It is for the procurement of Repatha 140 mg/mL SureClick medication, a specialty pharmaceutical product used for cardiovascular health treatment. The contract does not have a set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha 140 mg/mL SureClick medication, a specialty cardiovascular drug. The fixed-price contract is valued at $1,768.80 and has a period of performance through March 16, 2023. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,537.60, is for the procurement of Repatha (140 mg/mL) SureClick injectors. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $2,033.64 Delivery Order contract is for the supply of Repatha 140 mg/mL SureClick injections, a medication used to treat certain types of cardiovascular disease. The contract is a Firm Fixed Price arrangement with a performance period through May 31, 2024. It does not have a set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,096.67, is for the supply of Repatha 140 mg/mL SureClick medication. The contract has a firm fixed price and an ultimate completion date of December 11, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,742.10 firm fixed-price contract is for the supply of Repatha 140 mg/mL SureClick medication. The contract has a completion date of July 10, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (140 mg/mL SureClick) medication. The contract has a ceiling value of $2,103.96 and a period of performance through February 18, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FM95T
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,368.66, is for the delivery of Repatha 140 mg/mL SureClick injections, a specialty medication used to treat cardiovascular conditions. The contract has a period of performance through October 2024 and is a firm fixed-price, Indefinite Delivery Contract (IDC) vehicle that enables the DLA to efficiently procure a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive experience as a federal vendor and its significant DLA IDC, valued at $999,999,999 through 2026, position the company as a key supplier of critical medical commodities to the U.S. government.

Generated 2/27/25, 12:43 PM